Publication: Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer: real world experience.
dc.contributor.author | Bahçeci, Aykut | |
dc.contributor.author | Paydaş, Semra | |
dc.contributor.author | Ak, Naziye | |
dc.contributor.author | Ferhatoğlu, Ferhat | |
dc.contributor.author | Saip, Pınar Mualla | |
dc.contributor.author | Seydaoğlu, Gülşah | |
dc.contributor.author | Bilici, Mehmet | |
dc.contributor.author | Şimşek, MELİH | |
dc.contributor.author | Tekin, Salim Başol | |
dc.contributor.author | Çalikuşu, Züleyha | |
dc.contributor.author | Yavuz, Sinan | |
dc.contributor.author | Şahin, Ahmet Bilgehan | |
dc.contributor.author | Çubukçu, Erdem | |
dc.contributor.author | Evrensel, Türkkan | |
dc.contributor.author | Değirmencioğlu, Serkan | |
dc.contributor.author | Demiray, Atike Gökçen | |
dc.contributor.author | Yumuk, Perran Fulden | |
dc.contributor.author | Alan, Özkan | |
dc.contributor.author | Çikman, Duygu İlke | |
dc.contributor.author | Demirelli, Fuat Hulusi | |
dc.contributor.author | Köstek, Osman | |
dc.contributor.author | Gökyer, Ali | |
dc.contributor.author | Doğan, Mutlu | |
dc.contributor.author | Bal, Öznur | |
dc.contributor.author | Çakar, Burcu | |
dc.contributor.author | Gökmen, Erhan | |
dc.contributor.author | Yamaç, Deniz | |
dc.contributor.author | Korkmaz, Taner | |
dc.contributor.author | Aliyev, Altay | |
dc.contributor.author | Keskin, Özge | |
dc.contributor.author | Urvay, Semiha | |
dc.contributor.author | Büyükşimşek, Mahmut | |
dc.contributor.author | Karadeniz, Cemile | |
dc.contributor.author | Yildiz, Birol | |
dc.contributor.author | Yeşil Çinkir, Havva | |
dc.contributor.author | Demir, Hacer | |
dc.contributor.author | Beypinar, İsmail | |
dc.contributor.author | Karaçin, Cengiz | |
dc.contributor.author | Eser, Kadir | |
dc.contributor.author | Baykara, Meltem | |
dc.contributor.author | Kiliçkap, Saadettin | |
dc.contributor.author | Okutur, Kerem | |
dc.contributor.author | Bulut, Gülcan | |
dc.contributor.author | Alkan, Ali | |
dc.contributor.author | Arpaci, Erkan | |
dc.contributor.author | Pilanci, Kezban Nur | |
dc.contributor.author | Demir, Atakan | |
dc.contributor.author | Işik, Deniz | |
dc.contributor.author | Yildirim, Nilgün | |
dc.contributor.institutionauthor | ŞİMŞEK, MELİH | |
dc.date.accessioned | 2021-06-03T20:59:06Z | |
dc.date.available | 2021-06-03T20:59:06Z | |
dc.date.issued | 2021-05-20T00:00:00Z | |
dc.identifier.citation | Bahçeci A., Paydaş S., Ak N., Ferhatoğlu F., Saip P. M. , Seydaoğlu G., Bilici M., Şimşek M., Tekin S. B. , Çalikuşu Z., et al., -Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer: real world experience.-, Cancer investigation, ss.1-22, 2021 | |
dc.identifier.doi | 10.1080/07357907.2021.1933011 | |
dc.identifier.pubmed | 34014777 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12645/28954 | |
dc.title | Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer: real world experience. | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | aac8c4f6-ce5e-44fd-87c4-875edd940669 | |
local.indexed.at | PubMed | |
local.publication.goal | 03 - Sağlık ve Kaliteli Yaşam | |
local.publication.isinternational | 1 | |
relation.isAuthorOfPublication | 037fbf0b-fefb-4173-9f93-478d96e2926f | |
relation.isAuthorOfPublication.latestForDiscovery | 037fbf0b-fefb-4173-9f93-478d96e2926f | |
relation.isGoalOfPublication | 9c198c48-b603-4e2f-8366-04edcfc1224c | |
relation.isGoalOfPublication.latestForDiscovery | 9c198c48-b603-4e2f-8366-04edcfc1224c |